Cargando…
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
As small and stable high-affinity antigen binders, VHHs boast attractive characteristics both for therapeutic use in various disease indications, and as versatile reagents in research and diagnostics. To further increase the versatility of VHHs, we explored the VHH scaffold in a structure-guided app...
Autores principales: | van Schie, Loes, Van Breedam, Wander, Roels, Charlotte, Schepens, Bert, Frank, Martin, Mehdipour, Ahmad Reza, Laukens, Bram, Nerinckx, Wim, Santens, Francis, Devos, Simon, Rossey, Iebe, Thooft, Karel, Vanmarcke, Sandrine, Van Hecke, Annelies, Saelens, Xavier, Callewaert, Nico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208171/ https://www.ncbi.nlm.nih.gov/pubmed/37211816 http://dx.doi.org/10.1080/19420862.2023.2210709 |
Ejemplares similares
-
Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus
por: Gao, Xiaolong, et al.
Publicado: (2016) -
Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function
por: Tremblay, Jacqueline M., et al.
Publicado: (2020) -
A Molecular Dynamics Simulation of the Human Lysozyme – Camelid VHH HL6 Antibody System
por: Su, Zhi-Yuan, et al.
Publicado: (2009) -
Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics
por: Murakami, Taihei, et al.
Publicado: (2022) -
Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies
por: Chen, Baohua, et al.
Publicado: (2022)